NTEK vs NFLX valuation comparison.
When you
NTEK vs NFLX valuation comparison.
When you convert the NFLX O/S of 60 million and adjust its stock
price of over $400 and current yearly sales run of $5.2 Billion
you get an equivalent NFLX price of about $38 if it were based on
NTEK's current O/S of 633 million.
The table below reveals what NTEK could be trading at based on
its annual sales if it were being given an equivalent NFLX valuation.
I started posting this comparison 3 weeks ago when NTEK was
trading in the low .05's...Since then NTEK has made several
MAJOR announcements including the SONY ,BEST BUY and VIZIO
deals showing how rapidly their fundamentals are progressing.
The market has rewarded NTEK with a current price of .0859..
.But the table reveals NTEK is still greatly undervalued.
NFLX @ $38 / 633 million O/S > $5.2 Billion annual sales
NFLX @ $19 '' '' '' > $2.6 Billion annual sales
NFLX @ $9.5 '' '' '' > $1.3 Billion annual sales
NFLX @ $4.75 '' '' '' > $650 million annual sales
NFLX @ $2.37 '' '' '' > $325 million annual sales
NFLX @ $1.19 '' '' '' > $162 million annual sales
NFLX @ $.595 '' '' '' > $81 million annual sales
NFLX @ $.295 '' '' '' > $40.5 million annual sales
NFLX @ $.222 '' '' '' > $30.375 million annual sales
NFLX @ $.148 '' '' '' > $20.25 million annual sales
So by the chart we can see that NTEK being on pace to do $33 million
annual sales this year could easily be trading well above .222 cents if
it were getting an equivalent valuation that NFLX is getting right now.
Obviously some of the factors that will get NTEK much closer to that .222
valuation in the near future will be reporting their AUDITED FINANCIALS
and getting off the pinks sheets and onto a higher exchange.
But once they do that look how exciting the future gets.
With the successful rollout of the NP-1 and ULTRAFLIX this fall / winter
NTEK will be on pace to achieving $80-$120 million annual sales for
calendar 2015 from all their divisions in my opinion.
Notice on the chart above that would put NTEK in the .595 cent range
in 2015 going by the NFLX valuation.
Nanotech Entertainment Inc. (NTEK) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...
Continue Reading
New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...
Continue Reading
The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...
Continue Reading
Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...
Continue Reading
Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...
Continue Reading
Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...
Continue Reading
Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...
Continue Reading
High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...
Continue Reading
Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...
Continue Reading
Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding Orion Corporation's Executive Transactions Orion Corporation, a prominent player in the global pharmaceutical industry, has recently disclosed significant transactions involving its management, shedding light on financial movements that reflect company growth and strategy. Key Details on Managerial Transactions Recently, Orion Corporation reported under the...
Continue Reading
Strategy Inc. Increases Bitcoin Portfolio and Dividend Declaration Strategy Inc. MSTR has confirmed that it has not liquidated any shares or increased its holdings in Bitcoin BTC/USD for the specified period. The firm has also announced a cash divid
Continue Reading
Congressman Ritchie Torres Questions SEC's Use of Terminology Representative Ritchie Torres, a Democratic representative from New York, has recently shared his concerns about the phrase "digital asset security" as used by the U.S. Securities and Exchange Commission (SEC). He’s particularly interested in the legal basis and origins of this term. Congressional Dialogue...
Continue Reading
Investigation of Claims on Behalf of StubHub Investors Faruqi & Faruqi, LLP, a prominent name in national securities law, is currently looking into potential claims related to StubHub Holdings, Inc. (NYSE: STUB). This initiative aims to assist investors who might have faced losses due to the misleading statements made about the company's financial performance during its...
Continue Reading
Introduction to Sarepta Therapeutics Sarepta Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative therapies for rare diseases, particularly those associated with genetic factors. The company is well-known for its gene therapy treatments and aims to revolutionize treatment options for patients with Duchenne muscular dystrophy and similar...
Continue Reading